Wondering too how the $4 Paradigm targetIs being disseminated?
With 2 IRs, 2 full FDA approvals and 2 pending, aka touching cloth, why is it CTSO with no significant FDA advancemrnt or RCT data is worth 4 times our firm?
Furthermore how can the CFO participate in a financing made largely possible at 60 cents based on some heavily skewed accounting that easily could have been presented in a far more postive fashion. Dont worry bout that lil Tigris thing, we only need to achieve efficacy HALF of what we scored 10 years ago in Euphas phase II
More everything for those on the inner circle!
More posting than trading is a job well done kids!